A groundbreaking human trial has begun that could transform life for people with spinal cord injuries. The project, developed ...

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III ...

An international group of researchers has developed a new tool that can help identify problematic randomized controlled ...

Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has completed enrollment of its Phase 3 clinical trial (OPTIC-J) in Japan evaluating TEPEZZA for the treatment ...

Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...